Peter W. Nickerson

发表

A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice.

P. Nickerson, T. Strom, X. Zheng, 1997, Journal of immunology.

The Th1/Th2 paradigm and the allograft response.

P. Nickerson, R. Manfro, K. Wood, 1996, Current opinion in immunology.

IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice.

P. Nickerson, T. Strom, Yongsheng Li, 1999, Journal of immunology.

Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance?

P. Nickerson, T. Strom, X. Zheng, 1997, Transplantation.

Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML.

R. Arceci, P. Nickerson, T. Strom, 1996, Blood.

CTLA4Ig attenuates accelerated rejection (presensitization) in the mouse islet allograft model.

P. Nickerson, T. Strom, R. Manfro, 1997, Transplantation.

Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance.

P. Nickerson, T. Strom, X. Zheng, 1995, Journal of immunology.

IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection.

P. Nickerson, M. Zand, T. Strom, 1998, Journal of immunology.